
We have hit the tail end of the earnings season and the near last batch of movers follow result pronouncements …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

